India's Suven Life Sciences rises most in nearly 11 weeks on warrant issue
** Shares of drugmaker SUVP.NS rise as much as 10% to 90.8
rupees, marking their biggest intra day pct gain since Dec. 8,
2020
** SUVP said on Saturday it approved to issue 18.1 million
fully convertible warrants to promoters on a preferential basis
(https://bit.ly/2ZCyqhB)
** Shares have fallen 8.8% this year, as of last close
(Reporting by Philip George in Bengaluru)
((P.George@thomsonreuters.com; +91 8061822657; Reuters
Messaging: p.george@thomsonreuters.net))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees